1. Combination Treatment with PPARγLigand and Its Specific Inhibitor GW9662 Downregulates BIS and 14-3-3 Gamma, Inhibiting Stem-Like Properties in Glioblastoma Cells
   Chang-Nim Im, 2017, BioMed Research International CrossRef
2. Ferroptosis and PPAR-gamma in the limelight of brain tumors and edema
   Eduard Yakubov et al, 2023, Frontiers in Oncology CrossRef
3. Rosiglitazone suppresses human lung carcinoma cell growth through PPARγ-dependent and PPARγ-independent signal pathways
   ShouWei Han et al, 2006, Molecular Cancer Therapeutics CrossRef
4. Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma
   Cathy A. Payne et al, 2008, Molecular Cancer Therapeutics CrossRef